Literature DB >> 19466215

Metabolic syndrome and polycystic ovary syndrome... and vice versa.

Eleni Kandaraki1, Charikleia Christakou, Evanthia Diamanti-Kandarakis.   

Abstract

The metabolic syndrome (MS) and the polycystic ovary syndrome (PCOS) appear to be interrelated, although they are distinct entities. Women with PCOS appear to be commonly affected by MS, while women with MS may display reproductive or endocrine features of PCOS. These clinical observations appear to be only partly attributable to the association of both syndromes with obesity and imply a reciprocal pathophysiologic relationship between PCOS and MS with potentially significant clinical sequelae. Adult women with MS are at a greater risk of developing cardiovascular disease; women with PCOS also appear to carry such an increased risk in their postmenopausal life. Conversely, women with MS may experience reproductive disturbances, reminiscent of PCOS, more commonly than their counterparts from the general population. This review presented the current epidemiology of MS in adults and adolescents with PCOS, as well as the limited amount of data on the prevalence of features of PCOS among women with MS or MS features. We also discuss the potential pathophysiologic mechanisms underlying the relationship between these interweaving, but distinct, syndromes.

Entities:  

Mesh:

Year:  2009        PMID: 19466215     DOI: 10.1590/s0004-27302009000200014

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  20 in total

1.  Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.

Authors:  Xin Huang; Cuifang Hao; Hongchu Bao; Meimei Wang; Huangguan Dai
Journal:  J Assist Reprod Genet       Date:  2015-12-09       Impact factor: 3.412

2.  Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.

Authors:  Sarantis Livadas; Christos Pappas; Athanasios Karachalios; Evangelos Marinakis; Nikoleta Tolia; Maria Drakou; Philippos Kaldrymides; Dimitrios Panidis; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2014-04-22       Impact factor: 3.633

3.  An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women.

Authors:  Venkat Reddy Tumu; Suresh Govatati; Praveen Guruvaiah; Mamata Deenadayal; Sisinthy Shivaji; Manjula Bhanoori
Journal:  J Assist Reprod Genet       Date:  2013-10-10       Impact factor: 3.412

4.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Authors:  Zi-Jiang Chen; Han Zhao; Lin He; Yuhua Shi; Yingying Qin; Yongyong Shi; Zhiqiang Li; Li You; Junli Zhao; Jiayin Liu; Xiaoyan Liang; Xiaoming Zhao; Junzhao Zhao; Yingpu Sun; Bo Zhang; Hong Jiang; Dongni Zhao; Yuehong Bian; Xuan Gao; Ling Geng; Yiran Li; Dongyi Zhu; Xiuqin Sun; Jin-E Xu; Cuifang Hao; Chun-E Ren; Yajie Zhang; Shiling Chen; Wei Zhang; Aijun Yang; Junhao Yan; Yuan Li; Jinlong Ma; Yueran Zhao
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

5.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome.

Authors:  Yongyong Shi; Han Zhao; Yuhua Shi; Yunxia Cao; Dongzi Yang; Zhiqiang Li; Bo Zhang; Xiaoyan Liang; Tao Li; Jianhua Chen; Jiawei Shen; Junzhao Zhao; Li You; Xuan Gao; Dongyi Zhu; Xiaoming Zhao; Ying Yan; Yingying Qin; Wenjin Li; Junhao Yan; Qingzhong Wang; Junli Zhao; Ling Geng; Jinlong Ma; Yueran Zhao; Guang He; Aiping Zhang; Shuhua Zou; Aijun Yang; Jiayin Liu; Weidong Li; Baojie Li; Chunling Wan; Ying Qin; Juanzi Shi; Jing Yang; Hong Jiang; Jin-e Xu; Xiujuan Qi; Yun Sun; Yajie Zhang; Cuifang Hao; Xiuqing Ju; Dongni Zhao; Chun-e Ren; Xiuqing Li; Wei Zhang; Yiwen Zhang; Jiangtao Zhang; Di Wu; Changming Zhang; Lin He; Zi-Jiang Chen
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

6.  Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.

Authors:  V Vaggopoulos; E Trakakis; C Chrelias; P Panagopoulos; G Basios; S Makridima; V D Sioulas; G Simeonides; G Labos; E Boutati; D Kassanos
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256

7.  Importance of lipid accumulation product index as a marker of CVD risk in PCOS women.

Authors:  Joelma Ximenes Prado Teixeira Nascimento; Maria Bethânia da Costa Chein; Rosângela Maria Lopes de Sousa; Alexsandro dos Santos Ferreira; Paula Andrea Navarro; Luciane Maria Oliveira Brito
Journal:  Lipids Health Dis       Date:  2015-06-24       Impact factor: 3.876

Review 8.  Metabolic syndrome and its associated factors in Ethiopia: A systematic review and meta-analysis.

Authors:  Tadeg Jemere; Belayneh Kefale
Journal:  J Diabetes Metab Disord       Date:  2021-05-09

Review 9.  Polycystic ovary syndrome: clinical implication in perimenopause.

Authors:  Monika Lenart-Lipińska; Beata Matyjaszek-Matuszek; Ewa Woźniakowska; Janusz Solski; Jerzy S Tarach; Tomasz Paszkowski
Journal:  Prz Menopauzalny       Date:  2014-12-30

Review 10.  Metabolic disorders in menopause.

Authors:  Grzegorz Stachowiak; Tomasz Pertyński; Magdalena Pertyńska-Marczewska
Journal:  Prz Menopauzalny       Date:  2015-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.